EUDA HEALTH HOLDINGS LTD (EUDA) Fundamental Analysis & Valuation

NASDAQ:EUDA • VGG3142E1051

Current stock price

7 USD
-0.09 (-1.27%)
Last:

This EUDA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. EUDA Profitability Analysis

1.1 Basic Checks

  • In the past year EUDA has reported negative net income.
  • EUDA had a negative operating cash flow in the past year.
  • In the past 5 years EUDA reported 4 times negative net income.
  • EUDA had a negative operating cash flow in each of the past 5 years.
EUDA Yearly Net Income VS EBIT VS OCF VS FCFEUDA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 -5M -10M -15M

1.2 Ratios

  • With a Return On Assets value of -723.54%, EUDA is not doing good in the industry: 97.00% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -723.54%
ROE N/A
ROIC N/A
ROA(3y)-557.55%
ROA(5y)-334.4%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
EUDA Yearly ROA, ROE, ROICEUDA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 500 -500

1.3 Margins

  • The Gross Margin of EUDA (19.00%) is comparable to the rest of the industry.
  • EUDA does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 19%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
EUDA Yearly Profit, Operating, Gross MarginsEUDA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 -100 -200 -300

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. EUDA Health Analysis

2.1 Basic Checks

  • EUDA does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, EUDA has more shares outstanding
  • The debt/assets ratio for EUDA has been reduced compared to a year ago.
EUDA Yearly Shares OutstandingEUDA Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 10M 20M 30M
EUDA Yearly Total Debt VS Total AssetsEUDA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

  • EUDA has an Altman-Z score of -1.75. This is a bad value and indicates that EUDA is not financially healthy and even has some risk of bankruptcy.
  • EUDA's Altman-Z score of -1.75 is on the low side compared to the rest of the industry. EUDA is outperformed by 84.00% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -1.75
ROIC/WACCN/A
WACC8.95%
EUDA Yearly LT Debt VS Equity VS FCFEUDA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 20M 40M 60M 80M

2.3 Liquidity

  • EUDA has a Current Ratio of 0.23. This is a bad value and indicates that EUDA is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Current ratio value of 0.23, EUDA is not doing good in the industry: 93.00% of the companies in the same industry are doing better.
  • A Quick Ratio of 0.21 indicates that EUDA may have some problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 0.21, EUDA is doing worse than 92.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.23
Quick Ratio 0.21
EUDA Yearly Current Assets VS Current LiabilitesEUDA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 20M 40M 60M 80M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. EUDA Growth Analysis

3.1 Past

  • The earnings per share for EUDA have decreased by -9.30% in the last year.
  • EUDA shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 8.22%.
EPS 1Y (TTM)-9.3%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%94.51%
Revenue 1Y (TTM)8.22%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%60.23%

3.2 Future

  • The Earnings Per Share is expected to grow by 58.59% on average over the next years. This is a very strong growth
  • Based on estimates for the next years, EUDA will show a very strong growth in Revenue. The Revenue will grow by 112.08% on average per year.
EPS Next Y106.06%
EPS Next 2Y58.59%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year52.44%
Revenue Next 2Y112.08%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

EUDA Yearly Revenue VS EstimatesEUDA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2023 2024 2025 2026 5M 10M 15M 20M 25M
EUDA Yearly EPS VS EstimatesEUDA Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 0 0.1 -0.1 -0.2 -0.3

More info and screens

Find the best growth stocksShow best growing peers

2

4. EUDA Valuation Analysis

4.1 Price/Earnings Ratio

  • EUDA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Based on the Price/Forward Earnings ratio of 40.37, the valuation of EUDA can be described as expensive.
  • The rest of the industry has a similar Price/Forward Earnings ratio as EUDA.
  • When comparing the Price/Forward Earnings ratio of EUDA to the average of the S&P500 Index (23.10), we can say EUDA is valued expensively.
Industry RankSector Rank
PE N/A
Fwd PE 40.37
EUDA Price Earnings VS Forward Price EarningsEUDA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
EUDA Per share dataEUDA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.2 -0.4

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • EUDA's earnings are expected to grow with 58.59% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y58.59%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. EUDA Dividend Analysis

5.1 Amount

  • EUDA does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

EUDA Fundamentals: All Metrics, Ratios and Statistics

EUDA HEALTH HOLDINGS LTD

NASDAQ:EUDA (4/8/2026, 4:33:27 PM)

7

-0.09 (-1.27%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)06-14
Earnings (Next)N/A
Inst Owners0.12%
Inst Owner Change0%
Ins Owners18.16%
Ins Owner Change0%
Market Cap352.17M
Revenue(TTM)4.01M
Net Income(TTM)-15.36M
Analysts82.86
Price Target56.1 (701.43%)
Short Float %N/A
Short Ratio1.14
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)816.67%
PT rev (3m)816.67%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)-1.06%
Revenue NY rev (3m)-1.06%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 40.37
P/S 87.8
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.47
EYN/A
EPS(NY)0.17
Fwd EY2.48%
FCF(TTM)-0.04
FCFYN/A
OCF(TTM)-0.04
OCFYN/A
SpS0.08
BVpS-0.07
TBVpS-0.08
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -723.54%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 19%
FCFM N/A
ROA(3y)-557.55%
ROA(5y)-334.4%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover1.89
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 92.06%
Cap/Sales 2.98%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.23
Quick Ratio 0.21
Altman-Z -1.75
F-Score4
WACC8.95%
ROIC/WACCN/A
Cap/Depr(3y)85.16%
Cap/Depr(5y)58.08%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-9.3%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%94.51%
EPS Next Y106.06%
EPS Next 2Y58.59%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)8.22%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%60.23%
Revenue Next Year52.44%
Revenue Next 2Y112.08%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y34.88%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y22.18%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y26.06%
OCF growth 3YN/A
OCF growth 5YN/A

EUDA HEALTH HOLDINGS LTD / EUDA Fundamental Analysis FAQ

What is the fundamental rating for EUDA stock?

ChartMill assigns a fundamental rating of 2 / 10 to EUDA.


What is the valuation status of EUDA HEALTH HOLDINGS LTD (EUDA) stock?

ChartMill assigns a valuation rating of 2 / 10 to EUDA HEALTH HOLDINGS LTD (EUDA). This can be considered as Overvalued.


What is the profitability of EUDA stock?

EUDA HEALTH HOLDINGS LTD (EUDA) has a profitability rating of 0 / 10.


What is the expected EPS growth for EUDA HEALTH HOLDINGS LTD (EUDA) stock?

The Earnings per Share (EPS) of EUDA HEALTH HOLDINGS LTD (EUDA) is expected to grow by 106.06% in the next year.